Franklin Resources
NAGE

Franklin Resources’s Niagen Bioscience NAGE Stock Holding History

Franklin Resources’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,144
Closed -$44.7K – 3355
2026
Q1 		$44.7K Sell
10,144
-95,962
-90% -$518K ﹤0.01% 3019
2025
Q4 		$675K Buy
106,106
+4,623
+5% +$32.2K ﹤0.01% 2270
2025
Q3 		$947K Buy
101,483
+44,174
+77% +$446K ﹤0.01% 2131
2025
Q2 		$826K Buy
57,309
+4,863
+9% +$48K ﹤0.01% 2084
2025
Q1 		$362K Buy
52,446
+31,689
+153% +$199K ﹤0.01% 2400
2024
Q4 		$110K Buy
20,757
+760
+4% +$4.16K ﹤0.01% 2745
2024
Q3 		$68.2K Buy
+19,997
New +$62.9K ﹤0.01% 2774

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources's NAGE Position: Q2 2026 in Review

Franklin Resources sold out of Niagen Bioscience (NAGE) in Q2 2026, closing a stake of 10,144 shares — an estimated $44.7K sold.

Franklin Resources first reported a position in NAGE in Q3 2024 and held it in 7 quarters. The position peaked at $947K in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Franklin Resources reported no remaining Niagen Bioscience position as of Q2 2026 after selling out during the quarter.
  • Franklin Resources sold 10,144 Niagen Bioscience shares in Q2 2026, an estimated $44.7K.
  • Franklin Resources first reported a position in Niagen Bioscience in Q3 2024 and held it in 7 quarters.
  • Franklin Resources's Niagen Bioscience position peaked at $947K in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.